CUPR (Cuprina Holdings (Cayman)) FCF Margin %: -3,533.33% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CUPR Cuprina Holdings (Cayman) Ltd CUPR
10 GF Score
Price $4.22
! 6 Warning Signs
View Full Analysis

What is Cuprina Holdings (Cayman) FCF Margin %?

Cuprina Holdings (Cayman) CUPR -2.51% 10 FCF Margin % is -3,533.33% as of Dec. 2025. GuruFocus rates CUPR with a GF Score™ of 10/100. The stock has 6 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Cuprina Holdings (Cayman) ranks worse than 99.14% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cuprina Holdings (Cayman)'s Free Cash Flow for the six months ended in Dec. 2025 was $-0.74 Mil. Cuprina Holdings (Cayman)'s Revenue for the six months ended in Dec. 2025 was $0.02 Mil. Therefore, Cuprina Holdings (Cayman)'s FCF Margin % for the quarter that ended in Dec. 2025 was -3,533.33%.

As of today, Cuprina Holdings (Cayman)'s current FCF Yield % is -63.30%.

The historical rank and industry rank for Cuprina Holdings (Cayman)'s FCF Margin % or its related term are showing as below:

CUPR' s FCF Margin % Range Over the Past 10 Years
Min: -18369.23   Med: -2586.11   Max: -383.72
Current: -18369.23

During the past 5 years, the highest FCF Margin % of Cuprina Holdings (Cayman) was -383.72%. The lowest was -18369.23%. And the median was -2586.11%.

CUPR's FCF Margin % is ranked worse than
99.14% of 816 companies
in the Medical Devices & Instruments industry
Industry Median: -0.55 vs CUPR: -18369.23

Cuprina Holdings (Cayman) FCF Margin % Related Terms

Cuprina Holdings (Cayman) FCF Margin % Historical Data

* Premium members only.

The historical data trend for Cuprina Holdings (Cayman)'s FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cuprina Holdings (Cayman) FCF Margin % Chart

Cuprina Holdings (Cayman) Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
-383.72 -3,288.10 -951.32 -2,586.11 -18,261.54

Cuprina Holdings (Cayman) Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only -423.81 -2,130.00 -5,840.00 -35,677.78 -3,533.33

CUPR vs BNGO, UEEC, FEMY: FCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, Cuprina Holdings (Cayman)'s FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cuprina Holdings (Cayman) FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cuprina Holdings (Cayman)'s FCF Margin % distribution charts can be found below:

* The bar in red indicates where Cuprina Holdings (Cayman)'s FCF Margin % falls into.


CUPR
10GF Score
Cuprina Holdings (Cayman) Ltd CUPR
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cuprina Holdings (Cayman) FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Cuprina Holdings (Cayman)'s FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-7.122/0.039
=-18,261.54 %

Cuprina Holdings (Cayman)'s FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.742/0.021
=-3,533.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -3,533.33% mean?
Cuprina Holdings (Cayman) (CUPR) has a FCF Margin % of -3,533.33% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cuprina Holdings (Cayman) and its competitors. According to the industry distribution chart, Cuprina Holdings (Cayman) ranks #809 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 99.1%.
Is Cuprina Holdings (Cayman)'s FCF Margin % too high?
Cuprina Holdings (Cayman)'s current FCF Margin % is -3,533.33%. Based on the distribution chart, Cuprina Holdings (Cayman) ranks #809 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Cuprina Holdings (Cayman) has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Cuprina Holdings (Cayman)'s FCF Margin % compare to BNGO and UEEC?
According to the Medical Devices & Instruments industry distribution chart, Cuprina Holdings (Cayman) ranks #809 out of 816 companies for FCF Margin %. This places Cuprina Holdings (Cayman) in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cuprina Holdings (Cayman) and its competitors. Cuprina Holdings (Cayman)'s current FCF Margin % is -3,533.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cuprina Holdings (Cayman) stock overvalued right now?
Cuprina Holdings (Cayman) (CUPR) has a current FCF Margin % of -3,533.33%. The current FCF Margin % is -3,533.33%. Cuprina Holdings (Cayman)'s overall GF Score™ is 10/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Cuprina Holdings (Cayman) (CUPR), the current FCF Margin % is -3,533.33% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cuprina Holdings (Cayman) Business Description

Address c/o Blk 1090 Lower Delta Road No. 06-08, Singapore, SGP, 169201
Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.
10GF Score

Get the complete analysis for CUPR

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.22
Price